Clinical Trials Directory

Trials / Unknown

UnknownNCT03120442

Postoperative Delirium After Total Knee Arthroplasty Under Regional Anesthesia

Postoperative Delirium After Total Knee Arthroplasty Under Regional Anesthesia: a Comparison Between Intraoperative Sedation With Fentanyl, Fentanyl-dexmedetomidine and Fentanyl-propofol

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
600 (estimated)
Sponsor
Mahidol University · Academic / Other
Sex
All
Age
65 Years
Healthy volunteers
Accepted

Summary

Postoperative delirium after total knee replacement surgery has been related to significant morbidity and mortality among high risk patients. Anesthetic care might play a role in the development of postoperative delirium. The purpose of this study is to compare the incidence of postoperative delirium between different intraoperative sedation regimen. Delirium assessment using standardized screening tools will be done every 8 hours after surgery.

Detailed description

* In this randomized controlled trial, the investigator will compare the incidence of postoperative delirium after total knee arthroplasty between 3 intraoperative sedation regimens including (1) propofol-fentanyl (2) dexmedetomidine -fentanyl (3) fentanyl alone * Anesthesia techniques include spinal anesthesia and adductor canal block for postoperative analgesia. Sedation will be provide per group assignment. * After performance of regional anesthesia, sedation protocols will be used as followed: (1) target-controlled infusion of Propofol to achieve MOAA/S of 3-4 (2) incremental titration of Dexmedetomidine to achieve MOAA/S of 3-4 (3) supplemental fentanyl for anxiolysis. * Delirium will be screened by trained physicians, registered nurses every 8 hours postoperatively with validated Thai-version CAM-ICU (Confusion Assessment Method-Intensive Care Unit) until patient discharge. * Serum Interleukins (IL-1, IL-6) Tumor necrosis factor-Alpha and S100B protein from preoperative period will be compared with serum from postoperative period between delirium and non-delirium group. The level of serum biomarkers will be acquired in a 6-hour interval for 5 measurement points during the first postoperative day in the first 12 participants. The subsequent participants will have 1 measurement of serum biomarker during the first postoperative day. * Genetic profile for ApolipoproteinE genotype will be acquired and compared between delirium and non-delirium group.

Conditions

Interventions

TypeNameDescription
DRUGPropofoltarget-controlled infusion starting for Cet 0.1 mcg/ml to achieve MOAA/S 3-4
DRUGDexmedetomidineIncremental titration of dexmedetomidine starting from 0.1 mcg/kg/hr to achieve MOAA/S 3-4
DRUGFentanyl0.25 mcg fo Fentanyl for anxiolysis

Timeline

Start date
2017-06-14
Primary completion
2022-05-01
Completion
2022-08-01
First posted
2017-04-19
Last updated
2021-09-21

Locations

1 site across 1 country: Thailand

Source: ClinicalTrials.gov record NCT03120442. Inclusion in this directory is not an endorsement.